Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Esaote to boost imaging IT offering with 3mensio buy

This article was originally published in Clinica

Executive Summary

Italian radiology firm Esaote has acquired 3mensio Medical Imaging, in a bid to expand its presence in the healthcare IT market. Genoa-based Esaote has integrated the Dutch advanced visualisation technology developer into its Pie Medical Imaging subsidiary, which is also based in the Netherlands. Financial terms of the deal were not disclosed. 3mensio's 3D/4D visualisation technology is used in endovascular aneurysm repair (EVAR) and for transcatheter aortic valve implantation, to help surgeons plan procedures. Maastricht-based Pie Medical develops quantitative analysis software for cardiology and radiology applications, including its CAAS products. 3mensio's founder and CEO, Frank Wessels, will continue to lead the technical team in the new company, while CEO Paul Sysmans will remain involved as a consultant to the management.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT097063

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel